| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Total revenue | 107,206 | - |
| Product manufacturing costs | 48,382 | - |
| Stock based compensation and amortization expense | 5,939 | - |
| Other costs | 6,901 | - |
| Research and development | 49,909 | - |
| Sales and marketing | 20,842 | - |
| General and administrative | 50,136 | - |
| Total other income, net | 7,192 | - |
| Provision for (benefit from) income taxes | -3,349 | - |
| Net loss | -64,362 | -42,629 |
| Depreciation and amortization | 5,707 | 3,654 |
| Loss on write-off and disposal of property and equipment and right-of-use asset impairment | 106 | 85 |
| Gain on lease termination | 65 | 65 |
| Stock-based compensation | 33,553 | 21,724 |
| Reduction of revenue related to stock warrant issued to customer | 2,054 | 1,021 |
| Amortization of right-of-use asset | 3,868 | 2,509 |
| Accretion or amortization on short-term investments | 2,400 | 1,488 |
| Change in fair value of warrant liabilities | -8 | 229 |
| (recovery) provision for inventory write-down | -551 | 465 |
| Provision (recovery) of doubtful accounts | 120 | 137 |
| Realized gain on available for sale securities | 4 | 4 |
| Accounts receivable | 2,930 | -6,471 |
| Inventory | -455 | -2,049 |
| Prepaid expenses and other assets | 5,943 | 3,640 |
| Accounts payable | 9,216 | 6,425 |
| Accrued and other liabilities | 6,056 | 3,978 |
| Contract liabilities | -4,374 | -3,836 |
| Operating lease liability | -5,028 | -3,273 |
| Net cash used in operating activities | -24,530 | -6,188 |
| Proceeds from sale of property and equipment | 0 | 0 |
| Purchases of property and equipment | 3,143 | 1,441 |
| Purchase of short-term investments | 118,424 | 79,686 |
| Proceeds from sales of short-term investments | 90,000 | 57,250 |
| Net cash (used in) provided by investing activities | -31,567 | -23,877 |
| Proceeds from espp purchase | 980 | 980 |
| Proceeds from exercise of stock options | 83 | 48 |
| Repayment of borrowings | 0 | - |
| Payments received (remitted) to fund employees tax obligation for vested rsus | 2,440 | 357 |
| Proceeds from the issuance of common stock under at-the-market offering, net of commissions and fees | 94,057 | 58,798 |
| At-the-market offering costs for the issuance of common stock | 232 | 10 |
| Net cash provided by (used in) financing activities | 97,328 | 60,173 |
| Effect of exchange rates on cash and cash equivalents | 436 | 480 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 41,667 | 30,588 |
| Cash and cash equivalents at beginning of period | 48,099 | - |
| Cash and cash equivalents at end of period | 89,766 | - |
Ouster, Inc. (OUSTW)
Ouster, Inc. (OUSTW)